- 5 days & nights inpatient stay
- 1 quick follow-up appointments
Participants will be reimbursed $2,050 for participating in this study and this clinical trial has been approved by an independent ethics committee.
About the study
This study is investigating a medication designed to increase the activity of certain immune system cells, called T cells. T cells are a type of white blood cell involved in the body’s response to infection and disease. By increasing the effectiveness of these T cells the medication is hoped to improve the immune systems ability to target and eliminate cancer.
How do I find out more?
If you have already registered with us but would like more information about this study, please call 1800 243 733 or schedule a call back. You can also email us at firstname.lastname@example.org quoting “White Cell Study”.
If you are interested in participating and have not previously registered as a participant with us, fill in your details in the form below and we’ll be in touch soon!